We are live on
!
Find out more
EPIX
ESSA Pharma
EPIX
EPIX
Delisted
EPIX was delisted on the 8th of October, 2025.
45 hedge funds and large institutions have $84.1M invested in ESSA Pharma in 2022 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 9 increasing their positions, 17 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
38% more capital invested
Capital invested by funds: $61M → $84.1M (+$23.1M)
0.97% less ownership
Funds ownership: 76.68% → 75.72% (-0.97%)
17% less funds holding
Funds holding: 54 → 45 (-9)
47% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 17
50% less call options, than puts
Call options by funds: $109K | Put options by funds: $216K
53% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 17
Holders
45
Holders Change
-9
Holders Change %
-16.67%
% of All Funds
0.72%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
9
Reduced
17
Closed
17
Calls
$109K
Puts
$216K
Net Calls
-$107K
Net Calls Change
-$187K
Top Buyers
Top Sellers
| 1 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$2.84M |
| 2 |
RI
RTW Investments
New York
|
-$2.39M |
| 3 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$1.74M |
| 4 |
O
OrbiMed
New York
|
-$790K |
| 5 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
-$760K |
